scholarly journals Administration of gonadotropin-releasing hormone analog as adjunctive therapy in women systemic lupus erythematosus

1989 ◽  
Vol 32 (9) ◽  
pp. 1186-1188 ◽  
Author(s):  
Anna Catania ◽  
Ida Mangone ◽  
Paola Motta ◽  
Carlo Zanussi
1994 ◽  
Vol 37 (11) ◽  
pp. 1708-1709 ◽  
Author(s):  
Sachikio Miyagawa ◽  
Toshihiko Shirai ◽  
Ikuko Shimamota ◽  
Motolhiko Ichijo ◽  
Hiroaki Ueki

2021 ◽  
Vol 2021 (10) ◽  
Author(s):  
Stephanie Frade ◽  
Sean O'Neill ◽  
David Greene ◽  
Melainie Cameron

Lupus ◽  
1996 ◽  
Vol 5 (1_suppl) ◽  
pp. 23-27 ◽  
Author(s):  
V Nayak ◽  
Jm Esdaile

The use of antimalarial drugs to treat systemic lupus erythematosus (SLE) is receiving increased attention. A retrospective controlled study suggested that antimalarials were useful in suppressing disease activity in SLE. A randomized discontinuation trial of hydroxychloroquine sulphate supported the clinical belief that antimalarials are of benefit in SLE of mild to moderate disease activity and might have a role as adjunctive therapy to protect against more severe relapses of SLE. A randomized trial of the ability of hydroxychloroquine sulphate to suppress articular manifestations of SLE demonstrated no consistent statistically significant benefit, although the sample size was small. Anecdotal reports and the experience of expert clinicians have suggested a corticosteroid sparing role for antimalarials, although no controlled study has been conducted to specifically address this hypothesis. Thus, the evidence favors a role for antimalarials in suppressing mild to moderate disease activity in SLE and possibly in preventing severe disease exacerbations. Their role as corticosteroid sparing agents in SLE is widely believed, but unproven.


Author(s):  
Francis R. Comerford ◽  
Alan S. Cohen

Mice of the inbred NZB strain develop a spontaneous disease characterized by autoimmune hemolytic anemia, positive lupus erythematosus cell tests and antinuclear antibodies and nephritis. This disease is analogous to human systemic lupus erythematosus. In ultrastructural studies of the glomerular lesion in NZB mice, intraglomerular dense deposits in mesangial, subepithelial and subendothelial locations were described. In common with the findings in many examples of human and experimental nephritis, including many cases of human lupus nephritis, these deposits were amorphous or slightly granular in appearance with no definable substructure.We have recently observed structured deposits in the glomeruli of NZB mice. They were uncommon and were found in older animals with severe glomerular lesions by morphologic criteria. They were seen most commonly as extracellular elements in subendothelial and mesangial regions. The deposits ranged up to 3 microns in greatest dimension and were often adjacent to deposits of lipid-like round particles of 30 to 250 millimicrons in diameter and with amorphous dense deposits.


Sign in / Sign up

Export Citation Format

Share Document